Published in BMC Med Genomics on October 18, 2010
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol (2011) 1.67
APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol (2011) 1.43
African ancestry and genetic risk for uterine leiomyomata. Am J Epidemiol (2012) 1.14
Expected Shannon Entropy and Shannon Differentiation between Subpopulations for Neutral Genes under the Finite Island Model. PLoS One (2015) 0.88
Polymorphisms in vitamin D-related genes and risk of uterine leiomyomata. Fertil Steril (2014) 0.82
Insights into kidney diseases from genome-wide association studies. Nat Rev Nephrol (2016) 0.79
African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era. World J Nephrol (2015) 0.77
Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy. PLoS One (2017) 0.75
FASN, dietary fat intake, and risk of uterine leiomyomata in the Black Women's Health Study. Fertil Steril (2016) 0.75
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47
Common genetic variation and human traits. N Engl J Med (2009) 21.03
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
Methods for high-density admixture mapping of disease genes. Am J Hum Genet (2004) 12.02
A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87
The genetic structure and history of Africans and African Americans. Science (2009) 10.65
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A (2006) 10.32
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
Design and analysis of admixture mapping studies. Am J Hum Genet (2004) 7.20
The International HapMap Project Web site. Genome Res (2005) 5.96
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet (2010) 5.68
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA (1997) 5.09
A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet (2005) 5.02
Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet (2004) 4.51
Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med (1982) 4.48
Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet (2005) 4.04
A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet (2006) 3.77
Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet (2009) 3.60
Long-range LD can confound genome scans in admixed populations. Am J Hum Genet (2008) 3.06
Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies. Am J Hum Genet (2008) 3.06
The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01
Non-replication and inconsistency in the genome-wide association setting. Hum Hered (2007) 2.99
Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol (2002) 2.96
Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet (2010) 2.51
African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet (2010) 2.11
Survival advantage of black patients with kidney disease after acute myocardial infarction. Clin J Am Soc Nephrol (2006) 2.08
Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis (1988) 1.99
End-stage renal disease in developing countries. Kidney Int (2002) 1.98
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus (2002) 1.85
The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol (2005) 1.68
Hypertension-associated kidney disease: perhaps no more. J Am Soc Nephrol (2008) 1.68
Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int (2009) 1.48
A high-density admixture scan in 1,670 African Americans with hypertension. PLoS Genet (2007) 1.47
Charting the ancestry of African Americans. Am J Hum Genet (2005) 1.47
Social environmental stressors, psychological factors, and kidney disease. J Investig Med (2009) 1.39
The beauty of admixture. Nat Genet (2005) 1.33
Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.18
Population differentiation and migration: coalescence times in a two-sex island model for autosomal and X-linked loci. Theor Popul Biol (2008) 1.12
Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res (2000) 1.08
Admixture mapping of quantitative trait loci for blood lipids in African-Americans. Hum Mol Genet (2009) 1.04
End-stage renal failure in African Americans: insights in kidney disease susceptibility. Nephrol Dial Transplant (2002) 1.03
The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol (2010) 0.97
Linkage heterogeneity of end-stage renal disease on human chromosome 10. Kidney Int (2002) 0.97
Panel construction for mapping in admixed populations via expected mutual information. Genome Res (2008) 0.96
Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney Int (2002) 0.94
Statistical software for gene mapping by admixture linkage disequilibrium. Brief Bioinform (2007) 0.84
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet (2010) 5.68
Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA (2011) 4.07
The genome-wide structure of the Jewish people. Nature (2010) 3.37
Model-based inference of haplotype block variation. J Comput Biol (2004) 3.07
Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med (2012) 2.62
Most of the extant mtDNA boundaries in south and southwest Asia were likely shaped during the initial settlement of Eurasia by anatomically modern humans. BMC Genet (2004) 2.37
The matrilineal ancestry of Ashkenazi Jewry: portrait of a recent founder event. Am J Hum Genet (2006) 2.18
African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet (2010) 2.11
Absence of HIV-associated nephropathy in Ethiopians. Am J Kidney Dis (2006) 2.05
Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood (2010) 2.00
Polyadenylation of ribosomal RNA in human cells. Nucleic Acids Res (2006) 1.93
Counting the founders: the matrilineal genetic ancestry of the Jewish Diaspora. PLoS One (2008) 1.92
Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations. Hum Genet (2004) 1.85
Evidence for positive selection and population structure at the human MAO-A gene. Proc Natl Acad Sci U S A (2002) 1.79
Extended Y chromosome haplotypes resolve multiple and unique lineages of the Jewish priesthood. Hum Genet (2009) 1.77
Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet (2008) 1.67
Polyadenylation and degradation of human mitochondrial RNA: the prokaryotic past leaves its mark. Mol Cell Biol (2005) 1.67
The genetic legacy of religious diversity and intolerance: paternal lineages of Christians, Jews, and Muslims in the Iberian Peninsula. Am J Hum Genet (2008) 1.64
Optimizing exact genetic linkage computations. J Comput Biol (2004) 1.60
A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet (2006) 1.57
Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene. Am J Hum Genet (2009) 1.56
Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population. Am J Nephrol (2011) 1.52
A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet (2005) 1.51
Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet (2008) 1.49
Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J Biol Chem (2010) 1.45
Multiple origins of Ashkenazi Levites: Y chromosome evidence for both Near Eastern and European ancestries. Am J Hum Genet (2003) 1.44
APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol (2011) 1.43
APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease. Nephrol Dial Transplant (2012) 1.42
MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population. Eur J Hum Genet (2004) 1.40
High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria. Nephron Clin Pract (2013) 1.38
A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N Engl J Med (2010) 1.30
Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis. Am J Hum Genet (2008) 1.27
Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein. J Invest Dermatol (2007) 1.25
What does "a gene for heart disease" mean? A focus group study of public understandings of genetic risk factors. Am J Med Genet A (2003) 1.24
Hypertension-misattributed kidney disease in African Americans. Kidney Int (2013) 1.23
Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein. Nat Genet (2006) 1.22
The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus. Nat Rev Nephrol (2011) 1.22
A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduria. Kidney Int (2005) 1.21
Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal dysplasias caused by dominant mutations in KRT14. Am J Hum Genet (2006) 1.21
Gitelman's syndrome: a pathophysiological and clinical update. Endocrine (2011) 1.20
Attitudinal barriers to delivery of race-targeted pharmacogenomics among informed lay persons. Genet Med (2003) 1.15
Finding approximate tandem repeats in genomic sequences. J Comput Biol (2005) 1.15
Cell lineage analysis of the mammalian female germline. PLoS Genet (2012) 1.13
Maximum likelihood haplotyping for general pedigrees. Hum Hered (2005) 1.12
Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics (2011) 1.08
The Druze: a population genetic refugium of the Near East. PLoS One (2008) 1.08
Estimating genome-wide IBD sharing from SNP data via an efficient hidden Markov model of LD with application to gene mapping. Bioinformatics (2010) 1.07
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability. Blood (2012) 1.07
A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis. J Med Genet (2012) 1.03
The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res (2006) 1.01
The population genetics of the Jewish people. Hum Genet (2012) 1.00
Reconstruction of genealogical relationships with applications to Phase III of HapMap. Bioinformatics (2011) 0.98
Panel construction for mapping in admixed populations via expected mutual information. Genome Res (2008) 0.96
Population genetics of chronic kidney disease: the evolving story of APOL1. J Nephrol (2012) 0.96
Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells. FASEB J (2007) 0.95
Inferring ancestries efficiently in admixed populations with linkage disequilibrium. J Comput Biol (2009) 0.95
An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2003) 0.94
Pathway-based functional analysis of metagenomes. J Comput Biol (2011) 0.93
Efficient approximations for learning phylogenetic HMM models from data. Bioinformatics (2004) 0.92
Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer. Stem Cells (2012) 0.91
Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations. Clin Cancer Res (2009) 0.91
Integration of SNP genotyping confidence scores in IBD inference. Bioinformatics (2011) 0.90
An academic medical center under prolonged rocket attack--organizational, medical, and financial considerations. Acad Med (2009) 0.88
A system for exact and approximate genetic linkage analysis of SNP data in large pedigrees. Bioinformatics (2012) 0.87
Fetal programming of adult kidney disease: cellular and molecular mechanisms. Clin J Am Soc Nephrol (2007) 0.87
Regulation of APC/C (Cdh1) ubiquitin ligase in differentiation of human embryonic stem cells. Cell Cycle (2010) 0.87
Identification of a novel locus associated with congenital recessive ichthyosis on 12p11.2-q13. J Invest Dermatol (2005) 0.86
Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris. J Invest Dermatol (2012) 0.86
Homozygosity mapping of lethal congenital contractural syndrome type 2 (LCCS2) to a 6 cM interval on chromosome 12q13. Am J Med Genet A (2004) 0.86
Ancestry inference in complex admixtures via variable-length Markov chain linkage models. J Comput Biol (2013) 0.84
The association of DNA sequence variation at the MAOA genetic locus with quantitative behavioural traits in normal males. Hum Genet (2006) 0.83
The prodomain of a secreted hydrophobic mini-protein facilitates its export from the endoplasmic reticulum by hitchhiking on sorting receptors. J Biol Chem (2003) 0.83
Familial steroid-sensitive nephrotic syndrome in Southern Israel: clinical and genetic observations. Pediatr Nephrol (2007) 0.81
The implications of ENCODE for diagnostics. Nat Biotechnol (2012) 0.81
Quantitative digital in situ senescence-associated β-galactosidase assay. BMC Cell Biol (2011) 0.81
Ashkenazi Jewish centenarians do not demonstrate enrichment in mitochondrial haplogroup J. PLoS One (2008) 0.81
Linkage disequilibrium analysis reveals an albuminuria risk haplotype containing three missense mutations in the cubilin gene with striking differences among European and African ancestry populations. BMC Nephrol (2012) 0.80
Role of haptoglobin phenotype in end-stage kidney disease. Nephron Exp Nephrol (2004) 0.79
Population mixture model for nonlinear telomere dynamics. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.78
A murine transgenic model for transcriptional regulation of the Na/Pi-IIa major renal phosphate cotransporter. Am J Physiol Renal Physiol (2007) 0.78